title: Short-term femoral venous dialysis catheters for autologous peripheral blood progenitor cell collection: retrospective evaluation in 276 catheter practice from a single center.
abstract: We retrospectively evaluated 276 short-term femoral venous dialysis catheters (STFVCs) used for the collection of peripheral blood progenitor cells (PBPCs). Patients were not given any prophylactic antibiotic or anti-thrombotic therapy. Totally 877 leukapheresis sessions were performed. STFVCs were sufficient for continuous flow rate in all leukapheresis session. Side effects were detected in 30 (10.86%) STFVC practice (ecchymosis and/or hematoma in 13 (4.71%), thrombophlebitis in 5 (1.81%), bleeding in 4 (1.44%), catheters were not inserted into right femoral vein in 4 (1.44%), infection in PBPC products of 3 (1.08%) and blood receiving tip of catheter was cracked in 1 (0.36%)). Our results showed that STFVCs minimized the serious side effects such as thrombophlebitis, bleeding and infection of PBPC products. The STFVCs appeared safe and effective for PBPC collection.
authors.affiliation: Ege University Medical School, Department of Hematology, 35100 Bornova, Izmir, Turkey. ayhan.donmez@ege.edu.tr
authors.forename: Ayhan
authors.initials: A
authors.lastname: Donmez
authors.forename: Seckin
authors.initials: S
authors.lastname: Cagirgan
authors.forename: Murat
authors.initials: M
authors.lastname: Tombuloglu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods*; D004438:Ecchymosis / Q000209:etiology; D005260:Female; D005268:Femoral Vein; D006406:Hematoma / Q000209:etiology; D019650:Hematopoietic Stem Cell Mobilization / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007937:Leukapheresis / Q000295:instrumentation* / Q000379:methods*; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D012189:Retrospective Studies; D014182:Transplantation, Autologous; D016896:Treatment Outcome